Clinical Trial

Prospective Study of White Blood Cells

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to investigate white blood cells from volunteering donors to support the development of engineered regulatory T cell therapies.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2021-04-06; most recent amendment 2026-01-16.
Trial Details
NCT Number NCT04838171
Lead Sponsor Quell Therapeutics Limited
Conditions Autoimmune Diseases, Inflammation, Rejection; Transplant, Liver
Enrollment 10 participants
Start Date 2021-03-24
Primary Completion 2029-12-31 (estimated)
Study Completion 2030-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-21